6533b872fe1ef96bd12d4453
RESEARCH PRODUCT
Identification of normotensive patients with pulmonary embolism who may benefit from thrombolysis.
Karsten KellerLukas Hobohmsubject
medicine.medical_specialtybusiness.industrymedicine.medical_treatmentThrombolysismedicine.diseasePulmonary embolismFibrinolytic AgentsInternal medicinemedicineCardiologyHumansIdentification (biology)Thrombolytic TherapyCardiology and Cardiovascular MedicinebusinessPulmonary Embolismyear | journal | country | edition | language |
---|---|---|---|---|
2019-04-01 | International journal of cardiology |